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Further Evidence for Cancer as a Cell-Wall-
Deficient Mycobacterial Disease
Abstract
In	2014,	Buehring	reported	that	Bovine	Leukemic	Virus	(BLV),	a	common	oncogenic	
retrovirus	of	cattle,	was	present	in	some	humans,	primarily	localized	to	the	breast	
epithelium	―	the	very	cell	 type	from	which	most	breast	malignancies	arise.	By	
2015,	there	appeared	data	(Buehring,	2015)	supporting	that	as	many	as	37%	of	
human	breast	cancer	cases	could	be	attributable	to	BLV	exposure.	But	if	recent	
estimates	 suggest	 over	 83%	 of	 U.S.	 dairy	 operations	 are	 currently	 positive	 for	
BLV,	 they	also	 show	 that	approximately	68%	are	positive	 for	 cell-wall-deficient	
Mycobacterium avium	 subspecies	 paratuberculosis	 (MAP).	 Although	 tubercular	
lung	 infection	has	been	said	 to	 cause	11	times	 the	 incidence	of	 lung	cancer	as	
normal	 control	 subjects,	 it	 is	 its	 cell-wall-deficient	 (CWD)	 forms	 (also	 called	
L-forms)	that	have	recently	repeatedly	been	found	through	genetic	analysis	and	
appropriate	stains	 in	such	cancer	tissue	―	suggesting	that	CWD	tuberculosis	or	
atypical	tuberculosis	“is	 likely	to	be	 involved	 in	the	occurrence	or	development	
of	 lung	 carcinoma”.	A	 similar	 relationship	 between	 tubercular	 L-forms	 and	 the	
genesis	 of	 the	 very	 breast	 cancer	 addressed	 in	 the	 aforementioned	 BLV	 viral	
trials.	 This	 is	 not	 a	 coincidence.	 L-forms	 (CWD	 forms)	 predominate	 and	 are	
crucial	to	the	survival	of	mycobacteria	 in vivo	and	they	have	been	documented	
by	fluorescence	microscopy	in	all	intracellular	macrophage-grown	M. tuberculosis 
observed.	From	its	origin,	the	very	concept	of	the	“BLV	leukemic	virus"	has	been	
on	shaky,	unstable	ground.	In	1969,	veterinarians	Janice	and	Lyle	Miller	from	the	
University	of	Wisconsin-Madison	spotted	C-shaped	“virus-like”	particles	in	cattle	
lymposarcoma	insisting	that	these	were	similar	to	other	C-type	viruses	“regarded	
as	the	cause	of	leukemia	in	other	species.”	But	by	1978,	scientists	at	Downstate	
reported	 atypical	 mycobacterial	 forms,	 including	 its	 preferred	 filterable	 virus-
sized	 “L”	 or	 cell-wall-deficient	 (CWD)	 forms	 in	 not	 only	 leukemia	 but	 all	 other	
malignancies	―	all	having,	as	their	common	denominator	the	continuous	presence	
of	mycobacterial	C-shaped	forms.	
Tracing	 back	 to	 techniques	 similar	 to	Miller	 and	Millers	 original	 BLV	 study	we	
found	in	the	very	lyophilized	antigens	present	in	commercial	kits	for	the	diagnosis	
of	 BLV	 (AgBLV),	 these	 very	 same	 CWD	 (cell-wall-deficient)	 mycobacteria	 and	
mycobacterial	 DNA	 in	 all	 BLV	 samples	―	 which	 when	 introduced	 into	 guinea	
pigs	 stimulated	 the	 same	 antibody	 as	 occurred	 when	 mycobacteria-infected	
internal	organ	homogenates	themselves	were	injected	into	other	guinea	pigs.	It	
is	therefore	assumed	that	the	Bovine	Leukemic	Virus	(BLV)	is	being	mistaken	for	
viral-like	forms	of	cell-wall-deficient	(CWD)	atypical	tubercular	mycobacteria.	Since	
latent	tubercular	 infection,	as	well	as	 the	administration	of	BCG	and	tuberculin	
also	results	in	persistent	CWD	forms,	their	possible	role	in	carcinogenesis	is	also	
considered.	
Keywords: Cancer;	 Mycobacterium tuberculosis;	 Bovine	 leukemic	 virus;	
Mycobacteriophages
Received: October	07,	2016; Accepted: November	03,	2016; Published: November	
14,	2016
2016
Vol. 1 No. 1: 5
2
ARCHIVOS DE MEDICINA
ISSN 1698-9465
This article is available in: http://molecular-pathological-epidemiology.imedpub.com 
Journal of MPE Molecular Pathological Epidemiology
Introduction
BLV	or	the	Bovine	Leukemic	Virus	is	a	retrovirus.	Peyton	Rous	was	
credited	with	the	discovery	and	isolation	of	the	first	retrovirus.	By	
1911,	Rous	wanted	to	know	why	if	one	chicken	got	cancer,	others	
followed	[1].	Rous,	who	reproduced	the	malignant	tumor	at	will	in	
Plymouth	Rock	fowls,	favoured	a	bacterial	cause	over	a	filterable	
virus.	By	1933,	Shope	reported	a	viral	tumor	in	cottontail	rabbits,	
and	 Bittner	 reported	 on	 a	 milk-borne	 mouse	 breast	 cancer	
attributed	to	still	other	viruses	[2].	With	the	advent	of	the	electron	
microscope	by	the	1950s,	particles	later	questionably	ascribed	to	
retroviruses	were	readily	and	routinely	being	detected.	Indeed,	
as	Dutch	science	historian	Ton	van	Helvoort	pointed	out,	by	the	
1950s	the	word	"virus"	had	become	so	moldable	a	concept	that	
one	could	 speak	of	virus	workers	without	 the	existence	of	any	
consensus	whatsoever	of	what	viruses	were	[3].	
Post	 World	 War	 II	 investigators	 demonstrated	 that	 the	
retroviruses	 in	 the	 Rous,	 Bittner,	 and	 Shope	 tumours	 were	
actually	 filterable	 forms	 of	 mycobacteria	 [4].	 Tuberculosis-
like,	 these	 “viruses”	 could	 be	 variably	 stained	 with	 acid-fast	
dyes	and	readily	passed	through	a	filter,	but	were	 found	to	be	
mycobacterial	forms	of	the	Actinomycetales	having	many	of	the	
characteristics	 of	 mycobacteria	 such	 as	 tuberculosis.	 Virginia	
Livingston	of	Rutgers,	validated	earlier	work	done	proving	 that	
Rous’s	 virus	was	a	bacteria,	 a	finding	 soon	validated	by	others	
[5-8].	
At	 the	 height	 of	 this	 battle	 over	 whether	 viruses	 or	 atypical	
tubercular	mycobacteria	caused	cancer,	nothing	stood	out	more	
than	 the	 struggle	over	 the	etiology	of	 the	 “C-shaped	particle”.	
Miller	 and	 Miller,	 two	 of	 the	 veterinarians	 who	 “discovered”	
the	BLV	retrovirus	in	the	form	of	C-shaped	“virus-like	particles”	
in	 cattle	 lymphosarcoma,	 insisted	 that	 their	 C-shaped	particles	
were	 similar	 to	other	C-type	viruses	 “regarded	as	 the	cause	of	
leukemia	in	other	species”	[9,10]	(Figure 1).
Two	years	later,	Sorenson	et	al.,	saw	leukemia	as	more	accurately	
portrayed	as	not	being	transmitted	by	a	virus,	but	an	“infectious	
agent”	[11].	
Although	Robert	Huebner,	head	of	the	NIAID	at	the	time	bought	
fully	into	the	Miller’s	C-shaped	“virus”	as	the	most	likely	cause	of	
cancer	―	to	Dr.	Eleanor	Alexander-Jackson	of	Cornell,	C-shaped	
‘virus-like	 particles’	 had	 nothing	 to	 do	with	 viruses	 like	 BLV	 at	
all,	―	rather	 they	 represented	 round	 tubercular	mycobacterial	
L-forms	 that	 split	 into	a	 characteristic	 “C”,	 stainable	by	 special	
mycobacterial	stains,	one	of	which	she	herself	had	created	―	her	
“triple	stain”	[12]	(Figure 2).
Bacterial	 L-forms,	 the	 connecting	 link	 between	 viruses	 and	
bacteria,	 were	 first	 described	 by	 Klieneberger	 at	 England’s	
Lister	Institute,	for	which	she	named	them	“L-forms”	[13].	Such	
bacteria	were	‘cell-wall	deficient’	(CWD)	because	they	either	had	
a	disruption	in,	or	a	lack	of,	a	rigid	bacterial	cell	wall.	This	lack	of	
rigidity	allowed	bacteria	or	mycobacteria	the	plasticity	to	assume	
many	 forms	 (pleomorphic),	 some	 of	 them	 virus-like,	 but	 all	 of	
them	different	from	their	classical	parent.	Such	forms	were	also	
poorly	demonstrated	by	ordinary	staining,	while	many	of	them,	
just	like	viruses,	easily	passed	through	the	finest	of	filters.	Of	all	
the	 bacteria,	 it	 is	 tubercular	 L-forms	 (cell-wall-deficient	 forms)	
that	predominate	and	are	crucial	to	the	survival	of	tuberculosis	
and	 the	mycobacteria	 [14].	 It	 is	mostly	 in	 its	 cell-wall-deficient	
forms	 that	 TB	 can	 escape	 destruction	 by	 the	 body’s	 immune	
system.	And	at	the	same	time,	CWD	forms	of	the	tuberculosis-like	
mycobacteria	react	similarly	in	ELISA	blood	tests	to	retroviruses	
such	as	HIV,	which	they	can	simulate	in	every	way	[15].
By	 the	 twentieth	 century,	 polymorphic,	 partially	 acid-fast	 (AF),	
cell-wall-deficient	 (CWD),	 filter	 passing	 forms	 of	 tuberculosis	
were	 being	 isolated	 from	 tumor	 homogenates	 and	 the	 blood	
of	leukemic	patients	[16-24].	But	actually,	the	striking	similarity	
between	 cancer	 and	 tuberculosis-like	 microorganisms	 was	
noticed	 in	1877	by	 Sir	 John	Simon	―	 long	before	 the	 tubercle	
bacillus	was	even	discovered.	Research	in	the	last	two	decades	
does	nothing	but	confirm	this.	Repeatedly,	recent	studies	have	
shown	atypical	tubercular	cell-wall-deficient	forms	(also	known	
as	 “L-forms”),	 and	 tubercular	DNA	 integrated	 into	 the	genome	
of	 malignant	 tissue	 [25-34].	 However,	 since	 tuberculosis	 and	
the	development	of	a	malignant	tumor	can	proceed	at	the	same	
time,	more	objective	data	can	be	obtained	studying	tumor	cells	
cultivated	in vitro	[35].	One	convenient	way	to	do	this	is	to	study	
fetal	lamb	kidney	cells	infected	with	the	Bovine	Leukemic	Virus	
(FLK-BLV),	 whose	 antigens	 are	 available	 in	 irradiated	 filtered	
Pictograph	 showing	 a	 C-type	 “virus	 particle”	 from	
lymphocyte	 culture	 of	 a	 cow	 with	 	 lymphosarcoma	
as	shown	by	the	original	article	which	uncovered	BLV	
(92,000X)	[10].
Figure 1
Excerpt	 from	 one	 of	 the	 smears	 from	 Alexander-
Jackson’s	 lab,	 showing	 tubercular	 mycobacterial	
growth	 in	 leukemia	 on	 agar:	 their	 many	 formed	
(pleomorphic)	shapes	 including	two	large	 	C	forms	of	
which	one	is	shown.
Figure 2
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commercially	 available	 kits	 for	 the	 purpose	 of	 detecting	 the	
Bovine	Leukemic	Virus	(BLV).	
Despite	its	mixed	history,	leukemia	in	cattle	is	presently	thought	
to	be	caused	by	the	purportedly	oncogenic	bovine	leukemic	virus	
(BLV)	of	the	Retroviridae	family	which	is	said	to	cause	a	neoplastic	
proliferation	 of	 hematopoietic	 and	 lymphoid	 tissues	 that	 to	 a	
certain	extent	remains	a	problem	for	cattle	breeding.	Diagnostics	
for	 bovine	 leukemia	 are	 conducted	 by	 the	 detection	 of	 the	
antibody	of	BLV,	 in	particular	by	 the	agar	gel	 immunodiffusion	
(AGID)	 test,	using	 concentrated	FLK-BLV	culture	as	 the	antigen	
(AgBLV).	 Yet	 the	 existence	 of	 a	 relationship	 between	 the	
retroviruses	and	tuberculosis	has	 long	been	known.	Alexander-
Jackson	mentioned	a	tubercular-like	microbe	artificially	cultured	
from	 the	blood	and	 tumors	of	 all	 Rouse	 retrovirus	 (specifically	
called	 the	 “Rouse	 agent”	 by	 Rouse	 himself)	 infected	 chickens	
[34].	 Similarly	 Jackson	 isolated	 cultures	 similar	 to	 cell-wall-
deficient	(CWD)	tuberculosis	from	human	leukemia	[20].	
Just	as	it	is	known	that	injection	with	tuberculin	in	cattle	increases	
the	 level	of	antibodies	 to	antigens	of	BLV	and	that	 these	same	
BLV	antigens	 in	 turn	have	a	cross-reactivity	with	mycobacterial	
antigens	―	 it	 is	also	known	that	 the	p55	and	p24	 in	 the	HIV-1	
retrovirus	can	react	with	 the	blood	of	people	sick	with	 leprosy	
and	tuberculosis	[36,37].	For	all	of	these	reasons,	the	purpose	of	
this	study	was	to	 investigate	a	series	of	commercially	available	
antigen	diagnostics	presently	available	to	detect	bovine	leukemia	
(AgBLV)	for	the	possible	presence	of	mycobacteria	in	them.
Materials and Methods 
Twelve	 lots	of	AgBLV	for	AGID	made	 in	 the	Russian	Federation	
of	Belarus	from	1985	to	2013	were	used	(Table 1).	Commercially	
available	 lyophilized	 AgBLV	 was	 dissolved	 in	 growth	 stimulant	
MycCell	DW,	of	which	0.15	ml	was	distributed	on	standard	glass	
slides	 [38,39].	 Dried	 smears	 were	 fixed	 at	 65oC	 with	 3%	 H2O2 
and	 95%	methanol	 to	 inactivate	 endogenous	 peroxidase.	 This	
was	 followed	by	 Ziehl-Neelsen	and	Kinyoun	 staining	 as	well	 as	
a	modified	 immunoenzyme	 technique	 (MIET)	 that	 colors	 acid-
fast	 (AF)	 tubercular	 forms	 in	 red;	 non-acid-fast	 (NAF)	 forms	 in	
shades	 of	 brown,	 and	 non-tubercular	 microflora	 and	 tissues	
in	blue	 [39,40].	Results	were	 recorded	using	an	Olympus	56BX	
microscope.
AgBLV	 was	 dissolved	 in	 growth	 stimulant	 and	 then	 incubated	
for	48	hours	at	37°C.	After	that	0.3-0.5	ml	of	each	mixture	was	
placed	 in	 a	mycobacterial	 nutritive	medium	 (MycCel	DW),	 and	
incubated	for	10-15	days	at	37°C.	Resulting	colonies	were	then	
planted	on	the	same	nutritive	medium	[39,40].
The	bacterial	mass	of	the	two	 isolates	from	AgBLV	 lots	BN	and	
HC	(randomly	selected),	were	incubated	for	15	min	in	6%	oxalic	
acid	(1	mg/ml),	centrifuged,	and	then	suspended	in	the	growth	
stimulant	for	24h.	In	a	second	phase,	these	same	two	bacterial	
isolates	were	 incubated	 for	24	h	 in	 the	same	growth	stimulant	
with	0.15%	chlorhexidine	before	being	sown	on	the	same	growth	
medium.
To	determine	the	pathogenicity	of	isolates	obtained	from	AgBLV,	
we	used	 the	 isolates	 from	 lots	BN	and	HC	grown	on	6%	oxalic	
acid	 admixed	 with	 0.5	 ml	 of	 mineral	 oil	 were	 hypodermically	
administered	to	guinea	pigs	as	a	first	passage.	After	75	days	an	
autopsy	was	performed	and	1.5	ml	homogenates	of	their	internal	
organs	were	injected	into	new	guinea	pigs	for	a	second	passage.	
This	was	repeated	for	a	total	of	four	passages.	Homogenates	of	
internal	 organs	 decontaminated	 by	 6%	 oxalic	 acid	 were	 then	
incubated	in	growth	stimulant	and	sown	on	a	nutrient	medium	
(MycCel	DW).
With	regard	to	antisera,	purified	antibody	and	blood	serums,	we	
used:	
1.The	conjugated	antibodies	to	M. bovis	Valle	with	peroxidase	
Sigma	Type	IV,	previous	to	which	the	rabbit	antiserum	was	
absorbed	by	non-tubercular	microflora,	and	antibody	was	
purified	on	Affi-gel	10	(Bio	Rad	Laboratories)	with	antigens	
of	the	M. bovis	sonicate.
2.	Rabbit	antiserum	to	CWD	(Cell-Wall-Deficient)	M. bovis	8.
3.	Sheep	antiserum	to	CWD	M. tuberculosis	H37Rv.
4.	Six	sera	from	leukemic	cows	(AGID	positive).
5.	Three	sera	from	healthy	guinea	pigs.
Agar	 Gel	 Immunodiffusion	 (AGID)	 tests	 were	 done	 according	
the	 technique	 in	 the	 OIE	 Manual	 (2009)	 whereas	 SDS-PAGE	
electrophoresis	was	 done	 in	 15%	of	 PAGE	 [41].	 Bacterial	mass	
Lot numbers 
of AgBLV
Microscopy of AbBLV smears(10×100) Growth of AgBLV on MycCel DW
PCR of DNA isolates with primers 
16S rRNA
21/85 4	AF	rods,	brown	NAF	biofilm + Not	investigated
IEV 20	AF	rods,	brown	NAF	biofilm + +
BN 3	AF	rods,	brown	NAF	biofilm,	5	brown	rods + +
0805 3	AF	rods,	brown	granular	forms + Not	investigated
0506 4	AF	rods + +
0806 2	AF	rods,	brown	NAF	biofilm,	red	granular	forms + +
HC 3	AF	rods,	brown	NAF	biofilm + +
2	R Clusters	of	red	granular	forms	surrounding	brown	halos + +
3 Brown	NAF	biofilm	and	granular	forms + +
27 3	AF	rods,	brown	NAF	biofilm + +
30 Clusters	of	AF	rods,	brown	biofilms + +
38 Cluster	AF	rods	brown	rods	and	“network” + +
Table 1	Examined	Lots	of	AgBLV.
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isolates	were	destroyed	by	warming	them	for	5	minutes	at	100°C	
in	a	lysis	buffer.
Polymerase	 Chain	 Reaction	 (PCR):	 Isolates	 from	 AgBLV	 (0.2-
0.5	 mg/ml)	 were	 warmed-up	 for	 5	 min	 (95°C)	 in	 the	 lysis	
buffer.	The	DNA	was	isolated	on	columns	with	a	sorbent	(IBOH	
NANB)	 and	 amplification	was	 carried	 out	 on	 a	 C1000	 TouchTM 
Thermal	 Cycler	 (BioRad)	with	 16S	 rRNA	mycobacterial	 primers	
(Praymtech)	according	to	standard	protocols.	An	electrophoresis	
of	 amplificates	 was	 then	 carried	 out	 in	 2%	 agarose	 gel	 and	
results	obtained	from	a	Molecular	Imager®GelDocTM	XR+system	
(BioRad).
Results
Out	of	a	total	of	12	smears	performed	on	commercial	samples	of	
AgBLV,	10	of	them	(83%)	stained	acid-fast	(AF)	positive	as	classic	
red	tubercular	rods.	In	addition,	and	more	widely	prevalent	were	
non-acid-fast	(NAF)	forms	(rods,	cocci,	filaments),	which	reacted	
with	antibodies	to	M. bovis	and	stained	brown	with	MIET	(Table 
1) (Figures 3-15).	 In	addition	to	this	PCR	mycobacterial	primers	
for	16S	 rRNA	confirmed	 the	presence	of	mycobacterial	DNA	 in	
standard	BLV	antigens	(AgBLV)	used	to	detect	Bovine	Leukemic	
Virus	 (Figures 4, 6 and 7). All	samples	of	AgBLV	that	were	first	
incubated	in	a	mycobacterial	growth	stimulant	(48	hours	at	37°	
C)	 and	 then	 seeded	 on	MycCel	 DW	medium	 for	 from	 4	 to	 14	
days	yielded	NAF	(non-acid	fast)	mycobacterial	rods	and	coccoid	
forms	(Figure 5).	These,	along	with	most	of	the	10	lot	numbers	
of	AgBLV	that	had	classical	AF	tubercular	rods	were	confirmed	by	
PCR	with	mycobacterial	primers	to	16S	rRNA	(Figures 6 and 7). 
In	addition,	using	AGID,	 sonicates	of	 isolates	 from	AgBLV	were	
noted	to	have	identical	antigens	to	those	of	M. bovis	(Figure 8).
Smears	of	AgBLV:	3A	–	21/85,			3B	–	IEV;	3C	–	0506,	3D	-	НС,	
3E	–	30	(showing	cord	of	red	rods),	3F	–	30	Showing	cords	
of	red	rods	(black	arrows),	brown	biofilm	(blue	arrow).	A,	
D,	E,	F	–	MIET.	B	and	C:	Z-N	(10×100).
Figure 3
3A
21/85 IEV
3C 3D
3E 3F
0506
HC
30 30 (10x20)
PCR	of	DNA	isolated	with	16s	RNA	primers.	1.	Negative	
control,	2.	Mixture	of	AgBLV	all	lots,	3.	AgBLV	0506,	4.	
AgBLV	38,	5.	AgBLV	30,	6.	AgBLV	3,	7.	AgBLV	ВN.	K+	is	
used	as	a	positive	control.
Figure 4
Isolates	from	AgBLV	–	brown	(NAF)	and	red	(AF)	rods	
are	visible.		5A.	–21/85,	5B.	–	IEV,	5C.	–	BN,	5D.	–	0805,	
5E.	–	0506,	5F.	–	0806,	5G.	–	НС,	5H.	–	3,	5I.	–	27,	5J.	–	
30,	5K	–	38,	5L	–	2R.	(MIET,	10×100).
Figure 5
5C 5D
5K 38 5L
5J 30
2R
27
5H 3—
— —
—
——
5I
——
0506 0806
0805BN
5E 5F —
PCR	 of	 DNA	 with	 primers	 16S	 rRNA,	 10,	 20,	 30,	
using	 primary	 growth	 from	first	 and	 second	 passage	
isolates	of	AgBLV	IEV.	40	–	Shows	isolate	from	bovine	
tuberculin,	50	-	Negative	control,	a	marker	of	m.	m.;	K+ 
-	positive	control;	8.	CWD	M.	bovis	Vallee,	9.	M. bovis 
Vallee,	10Ꞌ–	Native	AgBLV	HC,	10	m.	Native	AgBVL	IEV.
Figure 6
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Practically	indestructible,	mycobacterial	isolates	from	AgBLV,	BN	
and	HC	both	kept	their	viability,	albeit	with	different	morphology	
from	 our	 original	 cultures,	 after	 being	 subjected	 to	 6%	 oxalic	
acid	 and	 0.15%	 chlorhexidine	 solution	 for	 24	 hours	 before	
placement	 in	MycCel	DW	growth	medium	 for	3-4	days	 (Figure 
9).	 Furthermore,	when	 isolates	 from	BN	and	HC	were	 injected	
into	guinea	pigs	after	being	subjected	to	6%	oxalic	acid,	cell-wall	
PCR	 of	 DNA	 isolates	 from	 AgBLV	 with	 primers	 16S	
rRNA.	 16.	 AgBLV	 30,	 15.	 AgBLV	 38,	 14.	 AgBLV	 3,	 13.	
AgBLV	 0506,	 20.	 AgBLV	 27.	 K+	 is	 used	 as	 a	 positive	
control.a
Figure 7
AGID:	antiserum	to	CWD	M. bovis	8	(Center	well).	Left	
upper	well	–	sonicate	of	M. bovis	8.	Right	upper	well	–	
sonicate	of	 isolate	 from	AgBLV	HC,	showing	 identical	
lines	(arrows).
Figure 8
Growth	 of	 	 	 isolates	 from	 AgBLV	 	 	 before	 and	 after	
incubation	 in	 6%	 oxalic	 acid	 and	 chlorhexidine:	 9A.	
BN	before,	9B.	BN	after	24	h	 in	0.15%	chlorhexidine,	
9C.	 BN	 after	 addition	 of	 oxalic	 acid,	 9D.	 HC	 before	
introduction	of	oxalic	acid	(coccoid	forms	-	arrows),	9E.	
HC	after	exposure	to	oxalic	acid	(MIET,	10×100).
Figure 9
9A 9B
9C 9D
9E
The	blood	of	guinea	pigs	46	days	after	inoculation	with	
isolates	from	AgBLV:	10A	and	10B	–	BN.	10C	and	10D	-	
HC.	The	clusters	red	(AF)	rods	and	dark	brown	staining	
in	leucocytes	are	visible	(MIET,	10×100).
Figure 10
10A 10B
10C 10D
AGID:	 AgBLV	 (central	 well)	 with	 sera	 of	 guinea	
pigs	 infected	 by	 the	 isolates	 from	 AgBLV	 HC	
(1)	 and	BN	 (2).	 3.	 Serum	 from	a	 leukemic	 cow.	
4.	 Antisera	 to	 CWD	M. tuberculosis.	 The	 white	
arrows	 indicate	 identical	 precipitates,	 whereas	
the	thin	lines	are	designated	by	red	arrows.
Figure 11
1 2
3 3
4 4
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deficient	forms	not	only	remained	alive	for	the	full	75	days	that	
specimens	were	observed,	but	within	46	days	displayed	classic	
red	 (AF)	 tubercular	 rods	 in	 their	 respective	 blood	 leukocytes	
(Figure 10).
Guinea	 pig	 blood	 from	 the	 first	 passage	 reacted	 in	 AGID	with	
AgBLV	 which	 in	 turn	 formed	 precipitates	 merging	 with	 those	
precipitates	formed	by	the	serum	of	a	sick	leukemic	cow.	These	
bovine	 leukemic	 precipitates	 then	 merged	 with	 precipitates	
formed	 by	 adding	 them	 to	 the	 antiserum	of	 cell-wall-deficient	
(CWD)	M. tuberculosis (Figure 11).	 During	 first	 passage	 guinea	
pig	autopsies,	 the	only	 lesions	visible	were	at	the	 injection	site	
and	inguinal	lymph	nodes	(lymphadenopathy).
After	 that	 initial	 passage	 from	 homogenates	 of	 the	 organs	 of	
guinea	pigs	 in	 first	 passage	of	 cultured	 samples	―	 those	 from	
BN	produced	granular	rods	and	cocci	whereas	isolates	from	HC	
contained	 cocci	 (Figure 9D)	 Isolates	 were	 specifically	 stained	
by	 the	 MIET	 or	 differential	 immunoperoxidase	 method.	 Their	
identity	 as	 mycobacteria	 was	 confirmed	 by	 PCR	 (Figure 13). 
And	both	cultures	were,	from	the	first	passage	sensitive	to	first-
line	 TB	 drugs	 such	 as	 Isoniazid,	 rifampicin,	 pyrazinamide,	 and	
ethambutol.
As	a	 second	passage	animal	organ	homogenates	 from	the	first	
passage	were	injected	into	uninfected	guinea	pigs.	Using	intervals	
The	 isolates	 from	 homogenates	 of	 internal	 organs	
used	 in	 the	 various	 passages	 through	 guinea	 pigs.	
12A	 shows	 the	mycobacteriological	 results	 after	 the	
first	 passage	with	BN.	 12B:	 the	 results	 after	 the	first	
passage	 using	HC.	 12C.	 The	 findings	 after	 the	 fourth	
passage	of	BN.	Cocci	are	shown	by	black	arrows,	while	
the	white	arrows	point	out	similar	NAF	mycobacterial	
granular	rods	(MIET,	10×10).
Figure 12
12A 12B
12C
PCR	 with	 primers	 16S	 rRNA	 for	 the	 DNA	 of	 isolates	
from	 homogenates	 of	 internal	 organs	 after	 passage	
in	 guinea	 pigs,	 including:	 2.	 Negative	 control,	 3.	 The	
third	passage	of	HC,	4.	The	third	passage	of	BN,	5.	The	
second	passage	of	HC.	6.	The	first	passage	of	HC	and	7.	
The	first	passage	of	BN.	K+	is	used	as	a	positive	control.
Figure 13
SDS-PAGE	 electrophoresis	 (15%).	 1-3	 –	 Isolates	
from	AgBLV	 lots	 30,	 IEV,	BN.	 4-6	–	 Isolates	 from	 the	
homogenates	 of	 internal	 organs	 through	 guinea	 pig	
passage	including	the	second	passage	of	HC,	the	first	
passage	of	HC,	and	the	third	passage	of	BN.
Figure 14
1       2        3      4          5        6
AGID	AgBLV	is	in	the	central	well.			Surrounding	wells	
contain	 the	 following:	 1.	 As	 a	 control,	 the	 positive	
serum	 of	 a	 leukemic	 cow	 (in	 well	 1).	 2-5:	 The	 sera	
of	 tissue	 homogenates	 of	 internal	 organs	 with	 their	
respective	passages,	namely:	HC	IV	passage	(in	well	2),	
BN	IV	passage	(in	well	3),	BN	III	passage	(in	well	4),	and	
HC	III	passage	(in	well	5).	Finally	in	well	6	is	the	serum	
of	negative	guinea	pigs.
Figure 15
1                 2
6 3
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of	from	75	to	80	days,	third	and	fourth	passages	of	these	organ	
biomaterials	were	carried	out.	Although	in	all	cases	rods	and	cocci	
could	 be	 identified	 through	 appropriate	 mycobacterial	 stain,	
there	existed	a	noticeable	difference	in	morphology	from	those	
cultures	isolated	from	the	initial	passage	(Figures 12A and 12C). 
Nevertheless	 that	 these	variant	 forms	were	mycobacterial	was	
confirmed	 through	 PCR	 (Figure 13).	 And	 they	 had	 polypeptide	
spectrums	 almost	 identical	 and	 not	much	 differing	 from	 those	
spectrums	obtained	from	native	isolates	of	AgBLV	(Figure 14).
Notice	 that	 sera	 from	 the	 second,	 third	 and	 fourth	 guinea	 pig	
passages,	which	reacted	in	AGID	with	AgBLV,	not	only	gave	lines	
identical	or	partially	identical	with	the	precipitate	of	serum	from	
a	sick	 leukemic	cow	―	but	they	also	reacted	with	the	sonicate	
of	CWD	M. bovis	BCG	(Figures 15 and 16). In	addition,	sonicates	
isolated	from	AgBLV	reacted	with	the	sera	of	 leukemic	cows	as	
well	as	commercially	standardized	AgBLVS	with	the	formation	of	
smoothly	merging	precipitates	or	partially	merging	precipitates	
(Figures 17 and 18).	Of	 interest	 is	 that	 serum	 from	 the	 fourth	
passage	 not	 only	 reacted	 with	 AgBLV,	 giving	 lines	 similar	 to	
isolated	 sonicates	 from	 AgBLV,	 but	 findings	 identical	 to	 those	
shown	for	tuberculin	(Figure 21).
Discussion
We	 found,	 in	 all	 cases,	 acid-fast	 [AF]	 and	 non-acid-fast	 [NAF]	
mycobacterial	 forms	 in	 addition	 to	 mycobacterial	 DNA	 in	
commercially	prepared,	widely	used	kits	containing	AgBLV	(BLV	
antigen)	 to	 diagnose	 professedly	 cancer-causing	 BLV.	 This	was	
despite	the	gamma	irradiation	and	the	filtering	of	culture	media	
common	 to	 the	 production	 of	 such	 standardized	 BLV	 antigen	
kits.	 In	 addition	our	 cultures	 and	diagnostics	of	 the	 lyophilized	
biomaterials	in	these	kits	―	based	on	morphology,	acid-fastness,	
common	 antigens	 and	 PCRs	 with	 mycobacterial	 16S	 rRNA	 left	
little	doubt	regarding	the	findings	of	classic	and	cell-wall-deficient	
tubercular	mycobacteria	which	cultures	out	on	fetal	lamb	kidney	
cells	 (FLK).	 Our	 results	 indicate	 that	 BLV	 is	 merely	 a	 viral-like	
mycobacteria	 capable	 of	 cultivation	 on	 FLK,	 resulting	 in	 either	
cell-wall-deficient	(CWD)	or	acid-fast	(AF)	mycobacterial	forms.	
Duesberg,	 who	 did	 much	 of	 the	 pioneer	 work	 on	 retroviral	
ultrastructure,	 never	 believed	 in	 the	 cancer-causing	 potential	
for	 retroviruses	 like	 the	 Bovine	 Leukemic	 Virus	 (BLV).	 Rather	
he	mentions	that	retroviruses	are	rather	widespread	in	healthy	
animals	and	humans	where	they	typically	cause	latent	infections	
and	 antiviral	 immunity	 and	 that	 “The	 leukemia	 risk	 of	 such	
AGID.	 In	Central	wells	are	the	serums	 	 	of	guinea	pig	
homogenates	 BN	 III	 passage	 (left	 part),	 and	 “HC	 III	
passage”	(right	part):	1.	AgBLV,	2.	M. bovis,	3.	Sonicate	
CWD		M. bovis	BC.
Figure 16
1                      2                                    1                        2 
3
3
AGID	of	BLV	infected	cow	sera	(In	surrounding	wells).	
In	Central	wells:	 17A	AgBLV	and	17B	 sonicate	of	 the	
isolate	from	AgBLV	IEV.
Figure 17
 
A B
AGID	of	serum	from	a	leukemic	cow	(in	central	well).	
Wells	 1	 through	 3	 contain:	 1.	 AgBLV	 (different	 lots	
of	 IEV),	 2.	 Sonicate	 of	 an	 isolate	 from	AgBLV	 IEV.	 3.	
Sonicate	of	an	isolate	from	AgBLV	BN.
Figure 18
1                      2
3
4
AGID	of	guinea	pig	serum	BN	from	a	fourth	passage	is	in	
the	Central	well,	while	Well	1	contains	AgBLV	(1:1);	Well	
2	contains	AgBLV	(1:4);	Well	3	has	sonicates	from	isolates	
of	tuberculin;	and	Well	4	sonicates	from	AgBLV	IEV.
Figure 19
1                           2
4                           3
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[retroviral]	infections	is	less	than	0.1%	and	thus	about	as	low	as	
that	of	virus-free	controls	 [42].”	And	even	as	 far	back	as	1957,	
Dmochowski,	 a	 virologist	 and	 electron	 microscopist	 at	 The	
University	of	Texas	M.D.	Anderson	Hospital	and	Tumor	Institute	
warned	this	about	attributing	“virus-like”	particles	such	as	found	
in	the	Miller’s	original	‘discovery’	of	Bovine	Leukemic	Virus	(BLV)	
as	the	direct	cause	of	cancer.	Dmochowski	and	Grey	said	this:	
“Unfortunately,	we	are	far	from	understanding	the	significance	
and	meaning	of	the	structure	of	viral	particles……no	matter	how	
exciting	electron	microscope	pictures	of	subcellular	particles	may	
look,	their	significance	can	be	properly	assessed	only	if	combined	
with	 suitable	 biological,	 biochemical,	 and	 other	 studies.	 This	
point	is	particularly	pertinent	to	studies	on	subcellular	particles	
of	 virus-like	 appearance	 that	may	 be	 found	 in	 neoplastic	 cells	
”[43].
In	 her	 own	 review	 of	 this	 subject	 thirteen	 years	 later	 Seibert	
mentions	the	cancer	findings	of	Demochowski	and	Grey	as	well	
as	 those	 of	 Dameshek	 in	 an	 altogether	 different	 light	 [43,44].	
These	viral	studies,	pointed	out	Seibert,	 found	 inclusion	bodies	
measuring	from	about	0.25-1.7	µ	 in	the	tissues	and	blood	cells	
of	patients	or	animals	with	leukemia	or	other	malignancies	[45].	
These	inclusion	bodies	in	turn	had	“virus-like”	inclusions	of	about	
0.03	 µ.	 Furthermore,	 it	 was	 not	 only	 striking	 to	 Seibert	 how	
closely	 such	 “virus-like”	measurements	approximated	 the	 sizes	
of	variably	acid-fast	bacterial	 forms	that	she	had	 isolated	 in	all	
cancers	[0.26-1.7	µ],	but	also	the	tiny	inclusions	that	she	likewise	
saw	within	these	mycobacterial	variably	acid-forms	―	measuring	
about	 0.01-0.05	 µ	 were	 similar	 in	 size,	 to	 certain	 phage	 ―	
specifically	 the	 same	mycobacteriophage	 that	Mankiewicz	 not	
only	 found	 in	 isolates	 from	 malignant	 tissues,	 but	 that	 were	
responsible	 for	 malignant	 change	 in	 those	mammalian	 tissues	
[46].	
Seibert	would	go	on	to	say:
"One	 of	 the	 most	 interesting	 properties	 of	 these	 bacteria	
[in	 all	 malignancies]	 is	 their	 great	 pleomorphism	 [ability	 to	
change	 form].	 For	 example,	 they	 readily	 change	 their	 shape	
from	 round	 cocci,	 to	 elongated	 rods,	 and	 even	 to	 thread-like	
filaments	 depending	 upon	 what	 medium	 they	 grow	 on	 and	
how	long	they	grow.	This	may	be	one	of	the	reasons	why	they	
have	 been	 overlooked	 (as	 cancer’s	 cause)	 or	 considered	 to	 be	
heterogeneous	contaminants	...	And	even	more	interesting	than	
this	is	the	fact	that	these	bacteria	have	a	filterable	form	in	their	
life	cycle;	that	is,	that	they	can	become	so	small	that	they	pass	
through	bacterial	filters	which	hold	back	bacteria.	 This	 is	what	
viruses	do,	and	is	one	of	the	main	criteria	of	a	virus,	separating	
them	from	bacteria.	But	the	viruses	also	will	not	live	on	artificial	
media	like	these	bacteria	do.	They	need	body	tissue	to	grow	on.	
Our	filterable	form,	however,	can	be	recovered	again	on	ordinary	
artificial	 bacterial	 media	 and	 will	 grow	 on	 these.	 This	 should	
interest	the	virus	workers	very	much	and	should	cause	them	to	
ask	 themselves	how	many	of	 the	viruses	may	not	be	filterable	
forms	of	our	bacteria	[47]."
Seibert’s	 cancer	 attentions	 were	 therefore	 not	 only	 riveted	
on	 pleomorphic,	 variable	 acid-fast,	 cell-wall-deficient	 (CWD)	
tubercular-like	 forms	 within	 her	 cancer	 tissue	 studies,	 but	
minute	 inclusions	 representative	 of	 mycobacteriophage.	
Mycobacteriophages	 are	 the	 virus	within	 all	 virulent	 infections	
of	 the	 Actinomycetales,	 whether	 tubercular,	 mycobacterial	 or	
related	 variable	 acid-fast	 species.	And	 it	was	 at	 this	 point	 that	
Florence	Seibert	speculated	as	to	just	how	the	nuclear	material	
of	 mammalian	 cells	 and	 tissues	 could	 become	 vulnerable	 to	
malignant	transformation	during	their	prolonged	and	apparently	
symbiotic	 residence	 in	 the	body.	 Specifically,	on	 the	 subject	of	
bacteriophage	 inspired	 carcinogenesis,	 Seibert	 modeled	 what	
she	felt	happened	along	the	lines	of	prophage	activation.
A	 prophage	 is	 the	 genome	 of	 a	 bacteriophage	 or	
mycobacteriophage	 (often	 simply	 called	 “phage”)	 which	 can	
incorporate	 into	 a	 bacteria’s	 DNA	 when	 phage	 lands	 on	 and	
attacks	a	bacteria,	injecting	its	nuclear	material	into	the	bacteria	
when	it	pierces	a	bacteria’s	cell	wall	(Figure 20).
Phage	 activation	occurs	when	 an	 insult	 or	 stress,	 such	 as	with	
Ultra-Violet	 (UV)	 light	 (which	 is	 also	 a	 human	 carcinogen)	
causes	 its	 bacterial	 host	 damage.	 When	 this	 happens,	 the	
prophage	of	phage	genetic	material,	already	lodged	in	bacterial	
chromosomes	 is	 then	 excised	 from	 them	 and	 can	 go	 into	 a	
reproductive	 cycle	 in	which	 the	 viral	 phage	 commandeers	 the	
bacterial	cell’s	reproductive	machinery.	Seibert	and	Mankiewicz,	
by	merely	 directing	 attention	 to	 the	 cytopathogenic	 effects	 of	
mycobacteriophage	on	mammalian	and	therefore	human	tissue,	
were	 merely	 pointing	 out	 what	 should	 have	 been	 an	 obvious	
mechanism	 behind	 cancer.	 Specifically,	 phage	 seemed	 to	 be	
directly	affecting	mammalian	cell	 reproduction	 in	a	similar	way	
to	 its	 actions	 on	 bacteria,	 but	 in	 this	 case	 eventually	 causing	
unmitigated	human	cell	division	[45,46].	
Much	 of	 the	 recent	 work	 regarding	 TB	 and	 its	 related	
microorganisms	as	causative	of	cancer	has	dealt	with	the	“L”	or	
“cell-wall-deficient”	 forms	of	typical	or	atypical	Mycobacterium 
tuberculosis.	Cell-wall-deficient	variants	can	produce	and	eject	as	
much	 as	 12	 to	 23	times	 as	many	phage	units	 into	mammalian	
tissue	as	comes	from	their	parent	microbes	[48,49].	
Recently	 Falagas	 reviewed	 14	 case	 reports	 that	 evaluated	 the	
history	of	TB	as	a	risk	factor	for	the	development	of	a	malignant	
Prophage	formation.Figure 20
prophage
2016
Vol. 1 No. 1: 5
9© Under License of Creative Commons Attribution 3.0 License
ARCHIVOS DE MEDICINA
ISSN 1698-9465Journal of MPE Molecular Pathological Epidemiology
tumor	[50].	But	the	median	time	between	the	initial	appearance	
of	 TB	 infection	 and	 the	 metachronous	 [appearing	 at	 different	
intervals]	 detection	 of	 malignancy	 averaged	 to	 be	 greater	
than	 20	 years,	 except	 in	 a	 single	 case	 that	 reported	 cancer	
development	after	only	11	months	of	 infection.	Falagas	et	al.’s	
data	strongly	suggests	that	TB	and	various	types	of	malignancies	
are	able	to	mimic	each	other	and	that	even	if	biopsy	specimens	
are	malignant,	they	should	also	be	sent	for	stain	and	culture	for	
M. tuberculosis	―	a	practice,	which,	as	in	the	various	BLV	trials,	
is	 practically	 never	 followed	 in	 laboratory	 or	 clinical	 studies.	
Falagas	reported	on	approximately	91	cases	in	which	TB	seemed	
to	 masquerade	 as	 malignant	 tumors.	 Most	 of	 these	 were	
based	on	clinical	or	 radiologic	evidence	of	a	malignancy	where	
histopathology	revealed	only	mycobacteria.
What	 is	 the	 nature	 and	 origin	 of	 these	 L-forms	 or	 cell-wall-
deficient	 forms	 of	 the	 tubercular	 mycobacteria	 that	 have	
captured	the	majority	of	attention	in	recent	cancer	studies?	
Nelson	and	Pickett	long	maintained	that	such	cell-wall-deficient	
(CWD)	states	were	largely	the	result	of	bacteriophage	or	in	the	
case	 of	 the	mycobacteria,	 mycobacteriophage	 attack	 with	 the	
other	purported	causes	simply	enhancing	phage	activity	to	throw	
the	cell	into	a	cell-wall-deficient	state	[51].	According	to	Nelson,	
why	 bacteria	 or	 mycobacteria	 became	 'cell-wall-deficient'	 and	
therefore	 assumed	many	 forms	 was	 simply	 the	 battering	 that	
their	bacterial	cell	walls	took	from	phage	attack.	Although	Nelson	
and	 Pickett	 acknowledged	 the	many	 conditions	 that	were	 said	
to	contribute	to	cell-wall	deficiency,	they	saw	all	of	these	other	
agents	 as	 simply	 activating	 such	phage	 intrusion.	 For	 example,	
they	 saw	 Kruger's	work	with	 penicillin,	 a	 known	 cause	 of	 cell-
wall-deficient	 forms,	 as	 just	 another	 substance	 that	 enhanced	
phage	 activity	 [52].	Moreover	Nelson	 and	 Pickett	 showed	 that	
such	phage	attack	could	keep	a	microorganism	locked	in	a	cell-
wall-deficient	state	indefinitely,	a	finding	which	dovetailed	with	
Takahashi's	 Japanese	 study	 of	 the	 different	 cell-wall-deficient	
forms	of	tuberculosis	[51,53].	
The	 role	 of	 mycobacteriophages,	 the	 viruses	 which	 live	 in	 all	
virulent	 tubercular	 and	 CWD	 mycobacteria	 has	 always	 been	
underestimated	 in	 the	genesis	of	cancer.	Livingston	noted	that	
there	was	no	viral	agent	that	was	equivalent	to	the	phage	which	
has	 been	 proven	 to	 be	 causative	 in	 cancer	 [4].	 This	 was	 only	
after	Mankiewicz	showed	that	mycobacteriophages	themselves	
could	 instigate	pre-malignant	human	tissue	change	–	the	same	
mycobacteriophages	that	could	be	activated	by	a	host	of	other	
environmental	 carcinogens,	 which	 essentially	 activated	 phage	
leading	to	their	multiplication,	extrusion	onto	mammalian	tissue	
and	the	cytopathologic	changes	which	this	caused	[46].
Further	 evidence	 for	 the	 role	 of	 CWD	 (cell-wall-deficient)	
mycobacteria	 and	 their	 mycobacteriophages	 in	 cancer	
lies	 in	 the	 ability	 of	 one	 mycobacteria,	 such	 as	 BCG	 (dilute	
Mycobacterium bovis)	to	combat	cancer	in	the	same	manner	one	
mycobacteria	(M. smegmatis),	transfected	with	the	appropriate	
mycobacteriophage	 can	 kill	 other	 mycobacteria,	 such	 as	
virulent	strains	of	M. avium	and	M. tuberculosis	[54].	Currently,	
bacillus	 Calmette-Guérin	 (BCG),	 a	 live	 attenuated	 strain	 of	
Mycobacterium bovis,	is	the	only	agent	approved	by	the	US	Food	
and	Drug	Administration	as	the	primary	therapy	of	carcinoma	in	
situ	 (CIS)	 of	 the	bladder.	 Studies	 have	 consistently	 shown	 that	
BCG	 treatment	 can	 eradicate	 this	 cancer	 in	 70%	 of	 patients	
with	CIS	of	the	bladder	when	used	correctly,	though	to	prevent	
cancer	recurrence,	long-term	maintenance	therapy	following	the	
induction	phase	is	necessary.
Although	the	mechanism	of	action	of	BCG	therapy	is	incompletely	
understood,	 once	 in	 the	 bladder,	 the	 live	 organisms	 enter	
macrophages,	where	they	induce	the	same	type	of	histologic	and	
immunologic	reaction	as	found	in	patients	with	tuberculosis.	BCG	
vaccine	ostensibly	enters	bladder	cancer	cells,	where	a	direct	cell-
to-cell	cytotoxic	response	seems	to	target	these	cancer	cells	for	
destruction.	The	precise	mechanism	as	seen	by	a	1993	University	
of	Illinois	study	was	that	initially	the	cancer	cells	seemed	to	eat	
(or	phagocytize)	and	thus	kill	the	Mycobacteria bovis	in	BCG.	But	
then,	suddenly,	the	cancer	cells	too	died.	Although	investigators	
in	 the	 study	 admitted	 the	 relationship	 wasn’t	 clear,	 again,	 a	
strong	 ‘tumoricidal	 agent’	 inside	 the	 Mycobacteria bovis	 or	
cow	 tuberculosis	 was	 pointed	 to,	 but	 obviously	 such	 death	 to	
the	 malignant	 cells	 could	 have	 been	 caused	 by	 BCG’s	 phage	
weaponry	[55].	
Thus,	what	 these	 investigators	were	 really	 probably	 looking	 at	
was	 a	 common	 phenomenon	 in	 nature	 known	 as	 ‘lysogeny’.	
Lysogeny	is	what	happens	when	one	colony	of	a	similar	bacteria	
kills	another	by	hurling	viral	phage	arsenal	 towards	 it	and	this,	
and	 the	 fact	 that	 phages	 are	 usually	 species	 specific,	 is	 what	
Virginia	Livingston	was	referring	to	when	she	said	that	it	seemed	
to	her	that	the	rationale	behind	why	BCG	was	effective	not	only	
against	 tuberculosis	 but	 cancer	was	 that	 both	 originated	 from	
closely	related	germs,	and	that	ultimately	the	phages	released	by	
the	Mycobacteria	in	BCG	were	therefore	able,	to	one	extent	or	
another,	effectively	kill	her	modified	mycobacterial	cancer	germ	
that	she	felt	was	behind	cancer.	
In	the	present	study,	the	growth	medium	MycCel	DW,	allowed	
the	 isolation	 from	 AgBLV	 and	 from	 subsequent	 guinea	 pigs	
SDS-PAGE	electrophoresis	(15%):		1.	Isolate	from	AgBLV	
BN	;		2.	Isolate	from	tuberculin.
Figure 21
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passages	 CWD	 tubercular	 cultures	 similar	 to	 isolates	 obtained	
from	 tuberculin	 (Figure 21).	 And	 Sera	 from	 such	 guinea	 pig	
passage	reacted	with	both	sonicates	from	AgBLV	and	tuberculin	
isolates	with	formation	of	identical	lines	(Figure 19).
Since	 latent	 tubercular	 infection,	 as	well	 as	 the	 administration	
of	 BCG	 and	 tuberculin	 also	 result	 in	 persistent	 tubercular	
CWD	 forms	 which	 can	 discharge	 phage	 systemically	 ―	 their	
possible	role	in	carcinogenesis,	although	not	proven,	cannot	be	
altogether	 ignored	 [38,56].	 Seibert	 speculated	 that	 it	 was	 the	
nuclear	material	 of	mammalian	 cells	 and	 tissues	 infected	with	
such	pleomorphic	CWD	bacteria	that	could,	over	time,	become	
vulnerable	 to	malignant	 transformation	either	 through	 contact	
with	the	chromatin	material	of	filterable	CWD	particles	or	their	
virulent	mycobacteriophages.	Whether	 latent	or	active	or	from	
the	mere	introduction	of	tuberculin	or	the	BCG	―	mycobacteria,	
once	 housed	 in	 the	 human	 macrophage	 assume	 cell-wall-
deficient	forms	[57].	
Such	 a	 potential	 for	 even	 latent	 forms	 of	 CWD	 to	 eventually	
instigate	 carcinogenesis	 of	 course	 depends	 upon	 the	 future	
virulence	of	the	dormant	microbes	introduced	into	the	body.	Yet	
phage,	which	can	actually	figure	into	the	eventual	pathogenicity	
of	TB,	is	once	again	instrumental	here.	Having	the	ability	to	alter	
many	bacterial	or	mycobacterial	properties,	phages	can	alter	all	
stages	 of	 the	 infectious	 process,	 including	 bacterial	 adhesion,	
colonization,	 increase	 of	 virulence,	 invasion,	 spread	 through	
human	 tissues;	 resistance	 to	 immune	 defenses;	 sensitivity	 to	
antibiotics;	and	transmissibility	among	humans	[58].	
The	 ability	 of	 CWD	 tubercular	 forms	 to	 have	 the	 ability	 to	
spring	back	to	lethal	classic	forms,	even	in	the	face	of	the	most	
extreme	environmental	 conditions	 in	a	 real	 sense	makes	 them	
‘immortal.’	 Falagas	 has	 indicated	 that	 the	 average	 latency	
between	 mycobacterial	 infection	 and	 the	 induction	 of	 cancer	
is	 approximately	 20	 years	 [49].	 We	 also	 know	 that	 latent	 or	
dormant	TB	maintains	the	right	to	become	active	virulent	TB.	In	
the	meantime	it	is	not	outside	the	realm	of	reason	to	say	that	it	
is	not	impossible	that	any	tubercular	content	introduced	into	the	
system	cannot	through	phage	intercession	be	integrated	into	the	
cells	and	tissues	of	the	body	resulting	in	certain	instances	in	the	
uncontrollable	reproduction	of	the	cells	and	tissues	of	our	body	
(Figure 22).
This	 study	 contradicts	 prevalent	 current	 ideas	 on	 the	 etiology	
of	 tumors	 and	 malignancy,	 particularly	 with	 regard	 to	 bovine	
leukemia,	 but	 not	 to	 the	 exclusion	 of	 other	 cancers.	We	 have	
suggested	a	core	cause	for	many	cancers	―	as	the	mycobacteria,	
related	Actinomycetales,	and	the	phages	within	them,	all	offers	
a	 likely	 prophage	 mechanism	 involved	 in	 carcinogenesis.	 Nor,	
should	 the	 fact	 that	 secondary	 ‘viruses’	and	bacteria	are	being	
picked-up	in	certain	cancer	studies	come	as	a	surprise	to	readers	
A	 TM4	 Mycobacteriophage	 virus	 injecting	 its	 DNA	
through	 the	 cell	 wall	 of	 Mycobacterium tuberculosis.	
When	this	bacterial	virus,	also	called	a	“phage”	or	in	this	
case	a	mycobacteriophage	infects	a	mycobacteria	such	
as	 tuberculosis,	 the	 germ	 itself	 becomes	 the	 phage’s	
workshop,	 the	 phage	 hijacking	 the	 machinery	 of	 the	
mycobacterial	cell,	turning	it	from	its	usual	purposes	to	
the	sole	task	of	 replicating	the	virus’s	genetic	material	
and	protein	coat.	So	effectively	can	this	happen,	with	so	
many	copies	of	the	mycobacteriopage	being	produced	–	
that	the	germ	can	eventually,	in	effect,	commit	suicide,	
bursting	under	 the	pressure	of	 phage	offspring.	 If	 this	
happens	then	multiplying	bacteriophages	are	set	free	–
to	infect	other	germs,	continuing	the	cycle.	But	in	other	
cases,	the	germ	lives	on,	with	its	DNA	altered,	creating	
changes	 in	 staining	 and	 pleomorphic	 architecture	
which	 become	 a	 diagnostic	 nightmare,	 as	 well	 as	
the	 potential	 of	 increasing	 the	 attacked	 microbe’s	
virulence	 or	 pathogenicity	 [48].	 It	 is	 postulated	 that	
such	mycobacteriophages	from	pathogens	such	as	fowl	
tuberculosis	 and	 Mycobacterium kansasii	 drastically	
increase	 the	 virulence	 of	 existing	 human	 tuberculosis	
often	acquired	early	in	life.
Figure 22
as	Koch	himself	taught	that	more	often	than	not	tuberculosis	is	
accompanied	by	secondary	pyogenic	bacteria.
Even	 if	 BLV	 is	 once	 and	 for	 all	 recognized	 as	 a	 product	 of	 the	
variability	of	TB,	in	no	way	does	its	persistence	in	the	body	alone	
always	initiate	oncogenesis.	Factors	such	as	the	condition	of	the	
immune	 system,	 the	 quantity	 and	 the	 pathogenicity	 of	 strains	
involved	and	many	other	factors	are	at	work.	Nevertheless,	the	
persistence	of	potentially	lethal	and	potentially	oncogenic	CWD	
forms	of	TB	and	related	species	of	the	Actinomycetales	―	either	
through	infection	or	vaccination	necessitates	its	continued	study	
and	surveillance	 for	cancer	development	on	a	global	 scale.	For	
latent,	 asymptomatic,	 CWD	 infection	 does	 not	 preclude	 the	
incessant	 bombardment	 of	 mammalian	 tissue	 with	 potentially	
oncogenic	phage.
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